The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biologics in Spine Surgery Market Research Report 2024
Synopsis
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
The global Biologics in Spine Surgery market was valued at US$ 2141 million in 2023 and is anticipated to reach US$ 3012.5 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Biologics in Spine Surgery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics in Spine Surgery.
Report Scope
The Biologics in Spine Surgery market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologics in Spine Surgery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics in Spine Surgery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
J & J
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
Segment by Type
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
Other
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biologics in Spine Surgery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biologics in Spine Surgery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
The global Biologics in Spine Surgery market was valued at US$ 2141 million in 2023 and is anticipated to reach US$ 3012.5 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Biologics in Spine Surgery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics in Spine Surgery.
Report Scope
The Biologics in Spine Surgery market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologics in Spine Surgery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics in Spine Surgery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
J & J
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
Segment by Type
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
Other
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biologics in Spine Surgery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biologics in Spine Surgery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Biologics in Spine Surgery Market Overview
1.1 Product Overview and Scope of Biologics in Spine Surgery
1.2 Biologics in Spine Surgery Segment by Type
1.2.1 Global Biologics in Spine Surgery Market Value Comparison by Type (2024-2030)
1.2.2 Bone Graft
1.2.3 Bone Graft Substitute
1.2.4 Platelet Rich Plasma (PRP)
1.2.5 Other
1.3 Biologics in Spine Surgery Segment by Application
1.3.1 Global Biologics in Spine Surgery Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Biologics in Spine Surgery Market Size Estimates and Forecasts
1.4.1 Global Biologics in Spine Surgery Revenue 2019-2030
1.4.2 Global Biologics in Spine Surgery Sales 2019-2030
1.4.3 Global Biologics in Spine Surgery Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Biologics in Spine Surgery Market Competition by Manufacturers
2.1 Global Biologics in Spine Surgery Sales Market Share by Manufacturers (2019-2024)
2.2 Global Biologics in Spine Surgery Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Biologics in Spine Surgery Average Price by Manufacturers (2019-2024)
2.4 Global Biologics in Spine Surgery Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biologics in Spine Surgery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biologics in Spine Surgery, Product Type & Application
2.7 Biologics in Spine Surgery Market Competitive Situation and Trends
2.7.1 Biologics in Spine Surgery Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Biologics in Spine Surgery Players Market Share by Revenue
2.7.3 Global Biologics in Spine Surgery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biologics in Spine Surgery Retrospective Market Scenario by Region
3.1 Global Biologics in Spine Surgery Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Biologics in Spine Surgery Global Biologics in Spine Surgery Sales by Region: 2019-2030
3.2.1 Global Biologics in Spine Surgery Sales by Region: 2019-2024
3.2.2 Global Biologics in Spine Surgery Sales by Region: 2025-2030
3.3 Global Biologics in Spine Surgery Global Biologics in Spine Surgery Revenue by Region: 2019-2030
3.3.1 Global Biologics in Spine Surgery Revenue by Region: 2019-2024
3.3.2 Global Biologics in Spine Surgery Revenue by Region: 2025-2030
3.4 North America Biologics in Spine Surgery Market Facts & Figures by Country
3.4.1 North America Biologics in Spine Surgery Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Biologics in Spine Surgery Sales by Country (2019-2030)
3.4.3 North America Biologics in Spine Surgery Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Biologics in Spine Surgery Market Facts & Figures by Country
3.5.1 Europe Biologics in Spine Surgery Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Biologics in Spine Surgery Sales by Country (2019-2030)
3.5.3 Europe Biologics in Spine Surgery Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biologics in Spine Surgery Market Facts & Figures by Country
3.6.1 Asia Pacific Biologics in Spine Surgery Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Biologics in Spine Surgery Sales by Country (2019-2030)
3.6.3 Asia Pacific Biologics in Spine Surgery Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Biologics in Spine Surgery Market Facts & Figures by Country
3.7.1 Latin America Biologics in Spine Surgery Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Biologics in Spine Surgery Sales by Country (2019-2030)
3.7.3 Latin America Biologics in Spine Surgery Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biologics in Spine Surgery Market Facts & Figures by Country
3.8.1 Middle East and Africa Biologics in Spine Surgery Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Biologics in Spine Surgery Sales by Country (2019-2030)
3.8.3 Middle East and Africa Biologics in Spine Surgery Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Biologics in Spine Surgery Sales by Type (2019-2030)
4.1.1 Global Biologics in Spine Surgery Sales by Type (2019-2024)
4.1.2 Global Biologics in Spine Surgery Sales by Type (2025-2030)
4.1.3 Global Biologics in Spine Surgery Sales Market Share by Type (2019-2030)
4.2 Global Biologics in Spine Surgery Revenue by Type (2019-2030)
4.2.1 Global Biologics in Spine Surgery Revenue by Type (2019-2024)
4.2.2 Global Biologics in Spine Surgery Revenue by Type (2025-2030)
4.2.3 Global Biologics in Spine Surgery Revenue Market Share by Type (2019-2030)
4.3 Global Biologics in Spine Surgery Price by Type (2019-2030)
5 Segment by Application
5.1 Global Biologics in Spine Surgery Sales by Application (2019-2030)
5.1.1 Global Biologics in Spine Surgery Sales by Application (2019-2024)
5.1.2 Global Biologics in Spine Surgery Sales by Application (2025-2030)
5.1.3 Global Biologics in Spine Surgery Sales Market Share by Application (2019-2030)
5.2 Global Biologics in Spine Surgery Revenue by Application (2019-2030)
5.2.1 Global Biologics in Spine Surgery Revenue by Application (2019-2024)
5.2.2 Global Biologics in Spine Surgery Revenue by Application (2025-2030)
5.2.3 Global Biologics in Spine Surgery Revenue Market Share by Application (2019-2030)
5.3 Global Biologics in Spine Surgery Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Biologics in Spine Surgery Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Biologics in Spine Surgery Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 J & J
6.2.1 J & J Corporation Information
6.2.2 J & J Description and Business Overview
6.2.3 J & J Biologics in Spine Surgery Sales, Revenue and Gross Margin (2019-2024)
6.2.4 J & J Biologics in Spine Surgery Product Portfolio
6.2.5 J & J Recent Developments/Updates
6.3 Stryker Corporation
6.3.1 Stryker Corporation Corporation Information
6.3.2 Stryker Corporation Description and Business Overview
6.3.3 Stryker Corporation Biologics in Spine Surgery Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Stryker Corporation Biologics in Spine Surgery Product Portfolio
6.3.5 Stryker Corporation Recent Developments/Updates
6.4 Nuvasive
6.4.1 Nuvasive Corporation Information
6.4.2 Nuvasive Description and Business Overview
6.4.3 Nuvasive Biologics in Spine Surgery Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nuvasive Biologics in Spine Surgery Product Portfolio
6.4.5 Nuvasive Recent Developments/Updates
6.5 Zimmer Biomet
6.5.1 Zimmer Biomet Corporation Information
6.5.2 Zimmer Biomet Description and Business Overview
6.5.3 Zimmer Biomet Biologics in Spine Surgery Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zimmer Biomet Biologics in Spine Surgery Product Portfolio
6.5.5 Zimmer Biomet Recent Developments/Updates
6.6 Orthofix International
6.6.1 Orthofix International Corporation Information
6.6.2 Orthofix International Description and Business Overview
6.6.3 Orthofix International Biologics in Spine Surgery Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Orthofix International Biologics in Spine Surgery Product Portfolio
6.6.5 Orthofix International Recent Developments/Updates
6.7 Globus Medical
6.6.1 Globus Medical Corporation Information
6.6.2 Globus Medical Description and Business Overview
6.6.3 Globus Medical Biologics in Spine Surgery Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Globus Medical Biologics in Spine Surgery Product Portfolio
6.7.5 Globus Medical Recent Developments/Updates
6.8 alphatec spine
6.8.1 alphatec spine Corporation Information
6.8.2 alphatec spine Description and Business Overview
6.8.3 alphatec spine Biologics in Spine Surgery Sales, Revenue and Gross Margin (2019-2024)
6.8.4 alphatec spine Biologics in Spine Surgery Product Portfolio
6.8.5 alphatec spine Recent Developments/Updates
6.9 K2M
6.9.1 K2M Corporation Information
6.9.2 K2M Description and Business Overview
6.9.3 K2M Biologics in Spine Surgery Sales, Revenue and Gross Margin (2019-2024)
6.9.4 K2M Biologics in Spine Surgery Product Portfolio
6.9.5 K2M Recent Developments/Updates
6.10 Exactech
6.10.1 Exactech Corporation Information
6.10.2 Exactech Description and Business Overview
6.10.3 Exactech Biologics in Spine Surgery Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Exactech Biologics in Spine Surgery Product Portfolio
6.10.5 Exactech Recent Developments/Updates
6.11 Wright Medical Technology
6.11.1 Wright Medical Technology Corporation Information
6.11.2 Wright Medical Technology Biologics in Spine Surgery Description and Business Overview
6.11.3 Wright Medical Technology Biologics in Spine Surgery Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Wright Medical Technology Biologics in Spine Surgery Product Portfolio
6.11.5 Wright Medical Technology Recent Developments/Updates
6.12 X-Spine
6.12.1 X-Spine Corporation Information
6.12.2 X-Spine Biologics in Spine Surgery Description and Business Overview
6.12.3 X-Spine Biologics in Spine Surgery Sales, Revenue and Gross Margin (2019-2024)
6.12.4 X-Spine Biologics in Spine Surgery Product Portfolio
6.12.5 X-Spine Recent Developments/Updates
6.13 Nutech
6.13.1 Nutech Corporation Information
6.13.2 Nutech Biologics in Spine Surgery Description and Business Overview
6.13.3 Nutech Biologics in Spine Surgery Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Nutech Biologics in Spine Surgery Product Portfolio
6.13.5 Nutech Recent Developments/Updates
6.14 Arthrex
6.14.1 Arthrex Corporation Information
6.14.2 Arthrex Biologics in Spine Surgery Description and Business Overview
6.14.3 Arthrex Biologics in Spine Surgery Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Arthrex Biologics in Spine Surgery Product Portfolio
6.14.5 Arthrex Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biologics in Spine Surgery Industry Chain Analysis
7.2 Biologics in Spine Surgery Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biologics in Spine Surgery Production Mode & Process
7.4 Biologics in Spine Surgery Sales and Marketing
7.4.1 Biologics in Spine Surgery Sales Channels
7.4.2 Biologics in Spine Surgery Distributors
7.5 Biologics in Spine Surgery Customers
8 Biologics in Spine Surgery Market Dynamics
8.1 Biologics in Spine Surgery Industry Trends
8.2 Biologics in Spine Surgery Market Drivers
8.3 Biologics in Spine Surgery Market Challenges
8.4 Biologics in Spine Surgery Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Biologics in Spine Surgery Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Biologics in Spine Surgery Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Biologics in Spine Surgery Market Competitive Situation by Manufacturers in 2023
Table 4. Global Biologics in Spine Surgery Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Biologics in Spine Surgery Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Biologics in Spine Surgery Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Biologics in Spine Surgery Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Biologics in Spine Surgery Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Biologics in Spine Surgery, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Biologics in Spine Surgery, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Biologics in Spine Surgery, Product Type & Application
Table 12. Global Key Manufacturers of Biologics in Spine Surgery, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biologics in Spine Surgery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics in Spine Surgery as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Biologics in Spine Surgery Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Biologics in Spine Surgery Sales by Region (2019-2024) & (K Units)
Table 18. Global Biologics in Spine Surgery Sales Market Share by Region (2019-2024)
Table 19. Global Biologics in Spine Surgery Sales by Region (2025-2030) & (K Units)
Table 20. Global Biologics in Spine Surgery Sales Market Share by Region (2025-2030)
Table 21. Global Biologics in Spine Surgery Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Biologics in Spine Surgery Revenue Market Share by Region (2019-2024)
Table 23. Global Biologics in Spine Surgery Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Biologics in Spine Surgery Revenue Market Share by Region (2025-2030)
Table 25. North America Biologics in Spine Surgery Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Biologics in Spine Surgery Sales by Country (2019-2024) & (K Units)
Table 27. North America Biologics in Spine Surgery Sales by Country (2025-2030) & (K Units)
Table 28. North America Biologics in Spine Surgery Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Biologics in Spine Surgery Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Biologics in Spine Surgery Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Biologics in Spine Surgery Sales by Country (2019-2024) & (K Units)
Table 32. Europe Biologics in Spine Surgery Sales by Country (2025-2030) & (K Units)
Table 33. Europe Biologics in Spine Surgery Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Biologics in Spine Surgery Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Biologics in Spine Surgery Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Biologics in Spine Surgery Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Biologics in Spine Surgery Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Biologics in Spine Surgery Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Biologics in Spine Surgery Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Biologics in Spine Surgery Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Biologics in Spine Surgery Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Biologics in Spine Surgery Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Biologics in Spine Surgery Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Biologics in Spine Surgery Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Biologics in Spine Surgery Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Biologics in Spine Surgery Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Biologics in Spine Surgery Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Biologics in Spine Surgery Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Biologics in Spine Surgery Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Biologics in Spine Surgery Sales (K Units) by Type (2019-2024)
Table 51. Global Biologics in Spine Surgery Sales (K Units) by Type (2025-2030)
Table 52. Global Biologics in Spine Surgery Sales Market Share by Type (2019-2024)
Table 53. Global Biologics in Spine Surgery Sales Market Share by Type (2025-2030)
Table 54. Global Biologics in Spine Surgery Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Biologics in Spine Surgery Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Biologics in Spine Surgery Revenue Market Share by Type (2019-2024)
Table 57. Global Biologics in Spine Surgery Revenue Market Share by Type (2025-2030)
Table 58. Global Biologics in Spine Surgery Price (US$/Unit) by Type (2019-2024)
Table 59. Global Biologics in Spine Surgery Price (US$/Unit) by Type (2025-2030)
Table 60. Global Biologics in Spine Surgery Sales (K Units) by Application (2019-2024)
Table 61. Global Biologics in Spine Surgery Sales (K Units) by Application (2025-2030)
Table 62. Global Biologics in Spine Surgery Sales Market Share by Application (2019-2024)
Table 63. Global Biologics in Spine Surgery Sales Market Share by Application (2025-2030)
Table 64. Global Biologics in Spine Surgery Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Biologics in Spine Surgery Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Biologics in Spine Surgery Revenue Market Share by Application (2019-2024)
Table 67. Global Biologics in Spine Surgery Revenue Market Share by Application (2025-2030)
Table 68. Global Biologics in Spine Surgery Price (US$/Unit) by Application (2019-2024)
Table 69. Global Biologics in Spine Surgery Price (US$/Unit) by Application (2025-2030)
Table 70. Medtronic Corporation Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Medtronic Biologics in Spine Surgery Product
Table 74. Medtronic Recent Developments/Updates
Table 75. J & J Corporation Information
Table 76. J & J Description and Business Overview
Table 77. J & J Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. J & J Biologics in Spine Surgery Product
Table 79. J & J Recent Developments/Updates
Table 80. Stryker Corporation Corporation Information
Table 81. Stryker Corporation Description and Business Overview
Table 82. Stryker Corporation Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Stryker Corporation Biologics in Spine Surgery Product
Table 84. Stryker Corporation Recent Developments/Updates
Table 85. Nuvasive Corporation Information
Table 86. Nuvasive Description and Business Overview
Table 87. Nuvasive Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Nuvasive Biologics in Spine Surgery Product
Table 89. Nuvasive Recent Developments/Updates
Table 90. Zimmer Biomet Corporation Information
Table 91. Zimmer Biomet Description and Business Overview
Table 92. Zimmer Biomet Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Zimmer Biomet Biologics in Spine Surgery Product
Table 94. Zimmer Biomet Recent Developments/Updates
Table 95. Orthofix International Corporation Information
Table 96. Orthofix International Description and Business Overview
Table 97. Orthofix International Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Orthofix International Biologics in Spine Surgery Product
Table 99. Orthofix International Recent Developments/Updates
Table 100. Globus Medical Corporation Information
Table 101. Globus Medical Description and Business Overview
Table 102. Globus Medical Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Globus Medical Biologics in Spine Surgery Product
Table 104. Globus Medical Recent Developments/Updates
Table 105. alphatec spine Corporation Information
Table 106. alphatec spine Description and Business Overview
Table 107. alphatec spine Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. alphatec spine Biologics in Spine Surgery Product
Table 109. alphatec spine Recent Developments/Updates
Table 110. K2M Corporation Information
Table 111. K2M Description and Business Overview
Table 112. K2M Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. K2M Biologics in Spine Surgery Product
Table 114. K2M Recent Developments/Updates
Table 115. Exactech Corporation Information
Table 116. Exactech Description and Business Overview
Table 117. Exactech Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Exactech Biologics in Spine Surgery Product
Table 119. Exactech Recent Developments/Updates
Table 120. Wright Medical Technology Corporation Information
Table 121. Wright Medical Technology Description and Business Overview
Table 122. Wright Medical Technology Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Wright Medical Technology Biologics in Spine Surgery Product
Table 124. Wright Medical Technology Recent Developments/Updates
Table 125. X-Spine Corporation Information
Table 126. X-Spine Description and Business Overview
Table 127. X-Spine Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. X-Spine Biologics in Spine Surgery Product
Table 129. X-Spine Recent Developments/Updates
Table 130. Nutech Corporation Information
Table 131. Nutech Description and Business Overview
Table 132. Nutech Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Nutech Biologics in Spine Surgery Product
Table 134. Nutech Recent Developments/Updates
Table 135. Arthrex Corporation Information
Table 136. Arthrex Description and Business Overview
Table 137. Arthrex Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Arthrex Biologics in Spine Surgery Product
Table 139. Arthrex Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Biologics in Spine Surgery Distributors List
Table 143. Biologics in Spine Surgery Customers List
Table 144. Biologics in Spine Surgery Market Trends
Table 145. Biologics in Spine Surgery Market Drivers
Table 146. Biologics in Spine Surgery Market Challenges
Table 147. Biologics in Spine Surgery Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biologics in Spine Surgery
Figure 2. Global Biologics in Spine Surgery Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Biologics in Spine Surgery Market Share by Type in 2023 & 2030
Figure 4. Bone Graft Product Picture
Figure 5. Bone Graft Substitute Product Picture
Figure 6. Platelet Rich Plasma (PRP) Product Picture
Figure 7. Other Product Picture
Figure 8. Global Biologics in Spine Surgery Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Biologics in Spine Surgery Market Share by Application in 2023 & 2030
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Global Biologics in Spine Surgery Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Biologics in Spine Surgery Market Size (2019-2030) & (US$ Million)
Figure 15. Global Biologics in Spine Surgery Sales (2019-2030) & (K Units)
Figure 16. Global Biologics in Spine Surgery Average Price (US$/Unit) & (2019-2030)
Figure 17. Biologics in Spine Surgery Report Years Considered
Figure 18. Biologics in Spine Surgery Sales Share by Manufacturers in 2023
Figure 19. Global Biologics in Spine Surgery Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Biologics in Spine Surgery Players: Market Share by Revenue in 2023
Figure 21. Biologics in Spine Surgery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Biologics in Spine Surgery Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Biologics in Spine Surgery Sales Market Share by Country (2019-2030)
Figure 24. North America Biologics in Spine Surgery Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Biologics in Spine Surgery Sales Market Share by Country (2019-2030)
Figure 28. Europe Biologics in Spine Surgery Revenue Market Share by Country (2019-2030)
Figure 29. Germany Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Biologics in Spine Surgery Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Biologics in Spine Surgery Revenue Market Share by Region (2019-2030)
Figure 36. China Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Biologics in Spine Surgery Sales Market Share by Country (2019-2030)
Figure 47. Latin America Biologics in Spine Surgery Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Biologics in Spine Surgery Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Biologics in Spine Surgery Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Biologics in Spine Surgery Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Biologics in Spine Surgery by Type (2019-2030)
Figure 57. Global Revenue Market Share of Biologics in Spine Surgery by Type (2019-2030)
Figure 58. Global Biologics in Spine Surgery Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Biologics in Spine Surgery by Application (2019-2030)
Figure 60. Global Revenue Market Share of Biologics in Spine Surgery by Application (2019-2030)
Figure 61. Global Biologics in Spine Surgery Price (US$/Unit) by Application (2019-2030)
Figure 62. Biologics in Spine Surgery Value Chain
Figure 63. Biologics in Spine Surgery Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
